Nishikaws S, Ogaws M, Kunisada T, et al. B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation [J]. Eur J Immunol, 1988, 18(11): 1767-1771.
[2]
Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor [J]. Proc Natl Acad Sci USA, 1994, 91(6): 2305-2309.
[3]
Roland J, Murphy BJ, Ahr B, et al. Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling [J]. Blood, 2003, 101(2): 399-406.
[4]
Wang J, Shiozawa Y, Wang Y, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer [J]. J Biol Chem, 2008, 283(7): 4283-4294.
[5]
Hartmann TN, Grabovsky V, Pasvolsky R, et al. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells [J]. J Leukoc Biol, 2008, 84(4): 1130-1140.
[6]
Kulbe H, Lebinson NR, Balkill F, et al. The chemokine network in cancer-much more than directing cell movement [J]. Int J Dev Biol, 2004, 48(5-6): 489-496.
[7]
Phillips RJ, Burdick MD, Lutz M, et al. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases [J]. Am J Respir Crit Care Med, 2003, 167(12): 1676-1686.
[8]
Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion [J]. Cell, 2005, 121(3): 335-348.
[9]
Raggo C, Ruhl R, Mcallister S, et al. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus [J]. Cancer Res, 2005, 65(12): 5084-5095.
[10]
Iwakiri S, Mino N, Takahashi T, et al. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer [J]. Cancer, 2009, 115(11): 2580-2593.
[11]
Meijer J, Ogink J, Roos E. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo [J]. Br J Cancer, 2008, 99(9): 1493-1501.
[12]
Libert F, Parmentier M, Lefort A, et al. Complete nucleotide sequence of a putative G protein coupled receptor: RDC1 [J]. Nucleic Acids Res, 1990, 18(7): 1917.
[13]
Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development [J]. J Exp Med, 2006, 203(9): 2201-2213.
[14]
Heesen M, Berman MA, Charest A, et al. Cloning and chromosomal mapping of an orphan chemokine receptor: mouse RDC1 [J]. Immunogenetics, 1998, 47(5):364-370.
[15]
Moepps B, Nuesseler E, Braun M, et al. A homolog of the human chemokine receptor CXCR1 is expressed in the mouse [J]. Mol Immunol, 2006, 43(7):897-914.
[16]
Balabanlan K, Lagane B, Infantino S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J]. J Biol Chem, 2005, 280(42): 35760-35766.
[17]
Gold SJ, Ni YG, Dohlman HG, et al. Regulators of G-protein signaling(RGS)proteins: region-specific expression of nine subtypes in rat brain [J]. J Neurosci, 1997, 17(20): 8024-8037.
[18]
Goldmann T, Dromann D, Radtke J, et al. CXCR7 transcription in human non-small cell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy [J]. Virchows Arch, 2008, 452(3): 347-348.
[19]
Barbero S, Bonavia R, Bajetto A, et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt [J]. Cancer Res, 2003, 63(8): 1969-1974.
[20]
Zou W, Machelon V, Coulomb L, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells [J]. Nat Med, 2001, 7(12): 1339-1346.
[21]
Hartmann TN, Burger JA, Glodek A, et al. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer(SCLC)cells [J]. Oncogene, 2005, 24(27): 4462-4471.
[22]
Sethi T, Rintoul RC, Moore SM, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo [J]. Nat Med, 1999, 5(6): 662-668.
[23]
Burger M, Hartmann T, Krome M, et al. Small peptide inhibitors of the CXCR4 chemokine receptor(CD184)antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells [J]. Blood, 2005, 106(5): 1824-1830.
[24]
Katayma A, Ogino T, Bandoh N, et al. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma [J]. Clin Cancer Res, 2005, 11(8): 2937-2946.
[25]
Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone [J]. Cancer Res, 2002, 62(6): 1832-1837.
[26]
Buunn, Montesinos-rongen M, Strack A, et al. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma [J]. Acta Neuropathol, 2007, 114(3): 271-276.
[27]
Sutton A, Friand V, Brule-donneger S, et al. Stromal cell-derived factor-1/chemokine(C-X-C motif)ligand 12 stimulates human hepatoma cell growth, migration, and invasion [J]. Mol Cancer Res, 2007, 5(1): 21-33.
[28]
Miao Z, Luker KE, Summers BC, et al. CXCR7(RDC1)promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature [J]. Proc Natl Acad Sci U S A, 2007, 104(40): 15735-15740.
